The global Mental Disorders Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Mental Disorders Drugs in various end use industries. The expanding demands from the Children, Adolescents and Adults,, are propelling Mental Disorders Drugs market. Drugs for Schizophrenia, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Antidepressants segment is estimated at % CAGR for the next seven-year period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Mental Disorders Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Mental Disorders Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Mental Disorders Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Mental Disorders Drugs sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Mental Disorders Drugs covered in this report include Johnson & Johnson, Pfizer, Eli Lilly, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb and Abbott Laboratories, etc.

The global Mental Disorders Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Johnson & Johnson

Pfizer

Eli Lilly

GlaxoSmithKline

AstraZeneca

Bristol-Myers Squibb

Abbott Laboratories

Scope of Mental Disorders Drugs - Market Report

Report Metric	Details
Report Name	Mental Disorders Drugs - Market
CAGR	5%
Global Mental Disorders Drugs market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Mental Disorders Drugs market, Segment by Type:	Drugs for Schizophrenia Antidepressants Antipsychotics Anxiolytics Drugs for the Treatment of Substance and Alcohol Addiction Drugs for Childhood and Adolescent Mental Illness Drugs to Treat Cognitive Disorders Sleep Disorders Others
Global Mental Disorders Drugs market, by Application	Children Adolescents Adults
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Mental Disorders Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Mental Disorders Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.

FAQ for this report

What are the Application segmentation covered in the Mental Disorders Drugs - Market report?

Ans: The Applications covered in the Mental Disorders Drugs - Market report are Children, Adolescents, Adults

What are the Type segmentation covered in the Mental Disorders Drugs - Market report?

Ans: The Types covered in the Mental Disorders Drugs - Market report are Drugs for Schizophrenia, Antidepressants, Antipsychotics, Anxiolytics, Drugs for the Treatment of Substance and Alcohol Addiction, Drugs for Childhood and Adolescent Mental Illness, Drugs to Treat Cognitive Disorders, Sleep Disorders, Others

1 Mental Disorders Drugs Market Overview

1.1 Mental Disorders Drugs Product Overview

1.2 Mental Disorders Drugs Market Segment by Type

1.2.1 Drugs for Schizophrenia

1.2.2 Antidepressants

1.2.3 Antipsychotics

1.2.4 Anxiolytics

1.2.5 Drugs for the Treatment of Substance and Alcohol Addiction

1.2.6 Drugs for Childhood and Adolescent Mental Illness

1.2.7 Drugs to Treat Cognitive Disorders

1.2.8 Sleep Disorders

1.2.9 Others

1.3 Global Mental Disorders Drugs Market Size by Type

1.3.1 Global Mental Disorders Drugs Market Size Overview by Type (2018-2029)

1.3.2 Global Mental Disorders Drugs Historic Market Size Review by Type (2018-2023)

1.3.3 Global Mental Disorders Drugs Forecasted Market Size by Type (2024-2029)

1.4 Key Regions Market Size Segment by Type

1.4.1 North America Mental Disorders Drugs Sales Breakdown by Type (2018-2023)

1.4.2 Europe Mental Disorders Drugs Sales Breakdown by Type (2018-2023)

1.4.3 Asia-Pacific Mental Disorders Drugs Sales Breakdown by Type (2018-2023)

1.4.4 Latin America Mental Disorders Drugs Sales Breakdown by Type (2018-2023)

1.4.5 Middle East and Africa Mental Disorders Drugs Sales Breakdown by Type (2018-2023)

2 Global Mental Disorders Drugs Market Competition by Company

2.1 Global Top Players by Mental Disorders Drugs Sales (2018-2023)

2.2 Global Top Players by Mental Disorders Drugs Revenue (2018-2023)

2.3 Global Top Players by Mental Disorders Drugs Price (2018-2023)

2.4 Global Top Manufacturers Mental Disorders Drugs Manufacturing Base Distribution, Sales Area, Product Type

2.5 Mental Disorders Drugs Market Competitive Situation and Trends

2.5.1 Mental Disorders Drugs Market Concentration Rate (2018-2023)

2.5.2 Global 5 and 10 Largest Manufacturers by Mental Disorders Drugs Sales and Revenue in 2022

2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Mental Disorders Drugs as of 2022)

2.7 Date of Key Manufacturers Enter into Mental Disorders Drugs Market

2.8 Key Manufacturers Mental Disorders Drugs Product Offered

2.9 Mergers & Acquisitions, Expansion

3 Mental Disorders Drugs Status and Outlook by Region

3.1 Global Mental Disorders Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029

3.2 Global Mental Disorders Drugs Historic Market Size by Region

3.2.1 Global Mental Disorders Drugs Sales in Volume by Region (2018-2023)

3.2.2 Global Mental Disorders Drugs Sales in Value by Region (2018-2023)

3.2.3 Global Mental Disorders Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)

3.3 Global Mental Disorders Drugs Forecasted Market Size by Region

3.3.1 Global Mental Disorders Drugs Sales in Volume by Region (2024-2029)

3.3.2 Global Mental Disorders Drugs Sales in Value by Region (2024-2029)

3.3.3 Global Mental Disorders Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)

4 Global Mental Disorders Drugs by Application

4.1 Mental Disorders Drugs Market Segment by Application

4.1.1 Children

4.1.2 Adolescents

4.1.3 Adults

4.2 Global Mental Disorders Drugs Market Size by Application

4.2.1 Global Mental Disorders Drugs Market Size Overview by Application (2018-2029)

4.2.2 Global Mental Disorders Drugs Historic Market Size Review by Application (2018-2023)

4.2.3 Global Mental Disorders Drugs Forecasted Market Size by Application (2024-2029)

4.3 Key Regions Market Size Segment by Application

4.3.1 North America Mental Disorders Drugs Sales Breakdown by Application (2018-2023)

4.3.2 Europe Mental Disorders Drugs Sales Breakdown by Application (2018-2023)

4.3.3 Asia-Pacific Mental Disorders Drugs Sales Breakdown by Application (2018-2023)

4.3.4 Latin America Mental Disorders Drugs Sales Breakdown by Application (2018-2023)

4.3.5 Middle East and Africa Mental Disorders Drugs Sales Breakdown by Application (2018-2023)

5 North America Mental Disorders Drugs by Country

5.1 North America Mental Disorders Drugs Historic Market Size by Country

5.1.1 North America Mental Disorders Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

5.1.2 North America Mental Disorders Drugs Sales in Volume by Country (2018-2023)

5.1.3 North America Mental Disorders Drugs Sales in Value by Country (2018-2023)

5.2 North America Mental Disorders Drugs Forecasted Market Size by Country

5.2.1 North America Mental Disorders Drugs Sales in Volume by Country (2024-2029)

5.2.2 North America Mental Disorders Drugs Sales in Value by Country (2024-2029)

6 Europe Mental Disorders Drugs by Country

6.1 Europe Mental Disorders Drugs Historic Market Size by Country

6.1.1 Europe Mental Disorders Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

6.1.2 Europe Mental Disorders Drugs Sales in Volume by Country (2018-2023)

6.1.3 Europe Mental Disorders Drugs Sales in Value by Country (2018-2023)

6.2 Europe Mental Disorders Drugs Forecasted Market Size by Country

6.2.1 Europe Mental Disorders Drugs Sales in Volume by Country (2024-2029)

6.2.2 Europe Mental Disorders Drugs Sales in Value by Country (2024-2029)

7 Asia-Pacific Mental Disorders Drugs by Region

7.1 Asia-Pacific Mental Disorders Drugs Historic Market Size by Region

7.1.1 Asia-Pacific Mental Disorders Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029

7.1.2 Asia-Pacific Mental Disorders Drugs Sales in Volume by Region (2018-2023)

7.1.3 Asia-Pacific Mental Disorders Drugs Sales in Value by Region (2018-2023)

7.2 Asia-Pacific Mental Disorders Drugs Forecasted Market Size by Region

7.2.1 Asia-Pacific Mental Disorders Drugs Sales in Volume by Region (2024-2029)

7.2.2 Asia-Pacific Mental Disorders Drugs Sales in Value by Region (2024-2029)

8 Latin America Mental Disorders Drugs by Country

8.1 Latin America Mental Disorders Drugs Historic Market Size by Country

8.1.1 Latin America Mental Disorders Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

8.1.2 Latin America Mental Disorders Drugs Sales in Volume by Country (2018-2023)

8.1.3 Latin America Mental Disorders Drugs Sales in Value by Country (2018-2023)

8.2 Latin America Mental Disorders Drugs Forecasted Market Size by Country

8.2.1 Latin America Mental Disorders Drugs Sales in Volume by Country (2024-2029)

8.2.2 Latin America Mental Disorders Drugs Sales in Value by Country (2024-2029)

9 Middle East and Africa Mental Disorders Drugs by Country

9.1 Middle East and Africa Mental Disorders Drugs Historic Market Size by Country

9.1.1 Middle East and Africa Mental Disorders Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

9.1.2 Middle East and Africa Mental Disorders Drugs Sales in Volume by Country (2018-2023)

9.1.3 Middle East and Africa Mental Disorders Drugs Sales in Value by Country (2018-2023)

9.2 Middle East and Africa Mental Disorders Drugs Forecasted Market Size by Country

9.2.1 Middle East and Africa Mental Disorders Drugs Sales in Volume by Country (2024-2029)

9.2.2 Middle East and Africa Mental Disorders Drugs Sales in Value by Country (2024-2029)

10 Company Profiles

10.1 Johnson & Johnson

10.1.1 Johnson & Johnson Company Information

10.1.2 Johnson & Johnson Introduction and Business Overview

10.1.3 Johnson & Johnson Mental Disorders Drugs Sales, Revenue and Gross Margin (2018-2023)

10.1.4 Johnson & Johnson Mental Disorders Drugs Products Offered

10.1.5 Johnson & Johnson Recent Development

10.2 Pfizer

10.2.1 Pfizer Company Information

10.2.2 Pfizer Introduction and Business Overview

10.2.3 Pfizer Mental Disorders Drugs Sales, Revenue and Gross Margin (2018-2023)

10.2.4 Pfizer Mental Disorders Drugs Products Offered

10.2.5 Pfizer Recent Development

10.3 Eli Lilly

10.3.1 Eli Lilly Company Information

10.3.2 Eli Lilly Introduction and Business Overview

10.3.3 Eli Lilly Mental Disorders Drugs Sales, Revenue and Gross Margin (2018-2023)

10.3.4 Eli Lilly Mental Disorders Drugs Products Offered

10.3.5 Eli Lilly Recent Development

10.4 GlaxoSmithKline

10.4.1 GlaxoSmithKline Company Information

10.4.2 GlaxoSmithKline Introduction and Business Overview

10.4.3 GlaxoSmithKline Mental Disorders Drugs Sales, Revenue and Gross Margin (2018-2023)

10.4.4 GlaxoSmithKline Mental Disorders Drugs Products Offered

10.4.5 GlaxoSmithKline Recent Development

10.5 AstraZeneca

10.5.1 AstraZeneca Company Information

10.5.2 AstraZeneca Introduction and Business Overview

10.5.3 AstraZeneca Mental Disorders Drugs Sales, Revenue and Gross Margin (2018-2023)

10.5.4 AstraZeneca Mental Disorders Drugs Products Offered

10.5.5 AstraZeneca Recent Development

10.6 Bristol-Myers Squibb

10.6.1 Bristol-Myers Squibb Company Information

10.6.2 Bristol-Myers Squibb Introduction and Business Overview

10.6.3 Bristol-Myers Squibb Mental Disorders Drugs Sales, Revenue and Gross Margin (2018-2023)

10.6.4 Bristol-Myers Squibb Mental Disorders Drugs Products Offered

10.6.5 Bristol-Myers Squibb Recent Development

10.7 Abbott Laboratories

10.7.1 Abbott Laboratories Company Information

10.7.2 Abbott Laboratories Introduction and Business Overview

10.7.3 Abbott Laboratories Mental Disorders Drugs Sales, Revenue and Gross Margin (2018-2023)

10.7.4 Abbott Laboratories Mental Disorders Drugs Products Offered

10.7.5 Abbott Laboratories Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis

11.1 Mental Disorders Drugs Key Raw Materials

11.1.1 Key Raw Materials

11.1.2 Key Raw Materials Price

11.1.3 Raw Materials Key Suppliers

11.2 Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Mental Disorders Drugs Industrial Chain Analysis

11.4 Mental Disorders Drugs Market Dynamics

11.4.1 Mental Disorders Drugs Industry Trends

11.4.2 Mental Disorders Drugs Market Drivers

11.4.3 Mental Disorders Drugs Market Challenges

11.4.4 Mental Disorders Drugs Market Restraints

12 Market Strategy Analysis, Distributors

12.1 Sales Channel

12.2 Mental Disorders Drugs Distributors

12.3 Mental Disorders Drugs Downstream Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

14.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Major Company of Drugs for Schizophrenia

Table 2. Major Company of Antidepressants

Table 3. Major Company of Antipsychotics

Table 4. Major Company of Anxiolytics

Table 5. Major Company of Drugs for the Treatment of Substance and Alcohol Addiction

Table 6. Major Company of Drugs for Childhood and Adolescent Mental Illness

Table 7. Major Company of Drugs to Treat Cognitive Disorders

Table 8. Major Company of Sleep Disorders

Table 9. Major Company of Others

Table 10. Global Mental Disorders Drugs Sales by Type 2018 VS 2022 VS 2029 (US$ Million)

Table 11. Global Mental Disorders Drugs Sales by Type (2018-2023) & (K Units)

Table 12. Global Mental Disorders Drugs Sales Market Share in Volume by Type (2018-2023)

Table 13. Global Mental Disorders Drugs Sales by Type (2018-2023) & (US& Million)

Table 14. Global Mental Disorders Drugs Market Share in Value by Type (2018-2023)

Table 15. Global Mental Disorders Drugs Price by Type (2018-2023) & (USD/Pcs)

Table 16. Global Mental Disorders Drugs Sales by Type (2024-2029) & (K Units)

Table 17. Global Mental Disorders Drugs Sales Market Share in Volume by Type (2024-2029)

Table 18. Global Mental Disorders Drugs Sales by Type (2024-2029) & (US$ Million)

Table 19. Global Mental Disorders Drugs Sales Market Share in Value by Type (2024-2029)

Table 20. Global Mental Disorders Drugs Price by Type (2024-2029) & (USD/Pcs)

Table 21. North America Mental Disorders Drugs Sales by Type (2018-2023) & (K Units)

Table 22. North America Mental Disorders Drugs Sales by Type (2018-2023) & (US$ Million)

Table 23. Europe Mental Disorders Drugs Sales (K Units) by Type (2018-2023)

Table 24. Europe Mental Disorders Drugs Sales by Type (2018-2023) & (US$ Million)

Table 25. Asia-Pacific Mental Disorders Drugs Sales (K Units) by Type (2018-2023)

Table 26. Asia-Pacific Mental Disorders Drugs Sales by Type (2018-2023) & (US$ Million)

Table 27. Latin America Mental Disorders Drugs Sales (K Units) by Type (2018-2023)

Table 28. Latin America Mental Disorders Drugs Sales by Type (2018-2023) & (US$ Million)

Table 29. Middle East and Africa Mental Disorders Drugs Sales (K Units) by Type (2018-2023)

Table 30. Middle East and Africa Mental Disorders Drugs Sales by Type (2018-2023) & (US$ Million)

Table 31. Global Mental Disorders Drugs Sales by Company (2018-2023) & (K Units)

Table 32. Global Mental Disorders Drugs Sales Share by Company (2018-2023)

Table 33. Global Mental Disorders Drugs Revenue by Company (2018-2023) & (US$ Million)

Table 34. Global Mental Disorders Drugs Revenue Share by Company (2018-2023)

Table 35. Global Market Mental Disorders Drugs Price by Company (2018-2023) & (USD/Pcs)

Table 36. Global Mental Disorders Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area

Table 37. Global Mental Disorders Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 38. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Mental Disorders Drugs as of 2022)

Table 39. Date of Key Manufacturers Enter into Mental Disorders Drugs Market

Table 40. Key Manufacturers Mental Disorders Drugs Product Type

Table 41. Mergers & Acquisitions, Expansion Plans

Table 42. Global Mental Disorders Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029

Table 43. Global Mental Disorders Drugs Sales by Region (2018-2023) & (K Units)

Table 44. Global Mental Disorders Drugs Sales Market Share in Volume by Region (2018-2023)

Table 45. Global Mental Disorders Drugs Sales by Region (2018-2023) & (US$ Million)

Table 46. Global Mental Disorders Drugs Sales Market Share in Value by Region (2018-2023)

Table 47. Global Mental Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

Table 48. Global Mental Disorders Drugs Sales by Region (2024-2029) & (K Units)

Table 49. Global Mental Disorders Drugs Sales Market Share in Volume by Region (2024-2029)

Table 50. Global Mental Disorders Drugs Sales by Region (2024-2029) & (US$ Million)

Table 51. Global Mental Disorders Drugs Sales Market Share in Value by Region (2024-2029)

Table 52. Global Mental Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2029)

Table 53. Global Mental Disorders Drugs Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 54. Global Mental Disorders Drugs Sales by Application (2018-2023) & (K Units)

Table 55. Global Mental Disorders Drugs Sales Market Share in Volume by Application (2018-2023)

Table 56. Global Mental Disorders Drugs Sales by Application (2018-2023) & (US$ Million)

Table 57. Global Mental Disorders Drugs Sales Market Share in Value by Application (2018-2023)

Table 58. Global Mental Disorders Drugs Price by Application (2018-2023) & (USD/Pcs)

Table 59. Global Mental Disorders Drugs Sales by Application (2024-2029) & (K Units)

Table 60. Global Mental Disorders Drugs Sales Market Share in Volume by Application (2024-2029)

Table 61. Global Mental Disorders Drugs Sales by Application (2024-2029) & (US$ Million)

Table 62. Global Mental Disorders Drugs Sales Market Share in Value by Application (2024-2029)

Table 63. Global Mental Disorders Drugs Price by Application (2024-2029) & (USD/Pcs)

Table 64. North America Mental Disorders Drugs Sales by Application (2018-2023) (K Units)

Table 65. North America Mental Disorders Drugs Sales by Application (2018-2023) & (US$ Million)

Table 66. Europe Mental Disorders Drugs Sales by Application (2018-2023) (K Units)

Table 67. Europe Mental Disorders Drugs Sales by Application (2018-2023) & (US$ Million)

Table 68. Asia-Pacific Mental Disorders Drugs Sales by Application (2018-2023) (K Units)

Table 69. Asia-Pacific Mental Disorders Drugs Sales by Application (2018-2023) & (US$ Million)

Table 70. Latin America Mental Disorders Drugs Sales by Application (2018-2023) (K Units)

Table 71. Latin America Mental Disorders Drugs Sales by Application (2018-2023) & (US$ Million)

Table 72. Middle East and Africa Mental Disorders Drugs Sales by Application (2018-2023) (K Units)

Table 73. Middle East and Africa Mental Disorders Drugs Sales by Application (2018-2023) & (US$ Million)

Table 74. North America Mental Disorders Drugs Sales by Country (2018-2023) & (K Units)

Table 75. North America Mental Disorders Drugs Sales Market Share in Volume by Country (2018-2023)

Table 76. North America Mental Disorders Drugs Sales by Country (2018-2023) & (US$ Million)

Table 77. North America Mental Disorders Drugs Sales Market Share in Value by Country (2018-2023)

Table 78. North America Mental Disorders Drugs Sales by Country (2024-2029) & (K Units)

Table 79. North America Mental Disorders Drugs Sales Market Share in Volume by Country (2024-2029)

Table 80. North America Mental Disorders Drugs Sales by Country (2024-2029) & (US$ Million)

Table 81. North America Mental Disorders Drugs Sales Market Share in Value by Country (2024-2029)

Table 82. Europe Mental Disorders Drugs Sales by Country (2018-2023) & (K Units)

Table 83. Europe Mental Disorders Drugs Sales Market Share in Volume by Country (2018-2023)

Table 84. Europe Mental Disorders Drugs Sales by Country (2018-2023) & (US$ Million)

Table 85. Europe Mental Disorders Drugs Sales Market Share in Value by Country (2018-2023)

Table 86. Europe Mental Disorders Drugs Sales by Country (2024-2029) & (K Units)

Table 87. Europe Mental Disorders Drugs Sales Market Share in Volume by Country (2024-2029)

Table 88. Europe Mental Disorders Drugs Sales by Country (2024-2029) & (US$ Million)

Table 89. Europe Mental Disorders Drugs Sales Market Share in Value by Country (2024-2029)

Table 90. Asia-Pacific Mental Disorders Drugs Sales by Region (2018-2023) & (K Units)

Table 91. Asia-Pacific Mental Disorders Drugs Sales Market Share in Volume by Region (2018-2023)

Table 92. Asia-Pacific Mental Disorders Drugs Sales by Region (2018-2023) & (US$ Million)

Table 93. Asia-Pacific Mental Disorders Drugs Sales Market Share in Value by Region (2018-2023)

Table 94. Asia-Pacific Mental Disorders Drugs Sales by Region (2024-2029) & (K Units)

Table 95. Asia-Pacific Mental Disorders Drugs Sales Market Share in Volume by Region (2024-2029)

Table 96. Asia-Pacific Mental Disorders Drugs Sales by Region (2024-2029) & (US$ Million)

Table 97. Asia-Pacific Mental Disorders Drugs Sales Market Share in Value by Region (2024-2029)

Table 98. Latin America Mental Disorders Drugs Sales by Country (2018-2023) & (K Units)

Table 99. Latin America Mental Disorders Drugs Sales Market Share in Volume by Country (2018-2023)

Table 100. Latin America Mental Disorders Drugs Sales by Country (2018-2023) & (US$ Million)

Table 101. Latin America Mental Disorders Drugs Sales Market Share in Value by Country (2018-2023)

Table 102. Latin America Mental Disorders Drugs Sales by Country (2024-2029) & (K Units)

Table 103. Latin America Mental Disorders Drugs Sales Market Share in Volume by Country (2024-2029)

Table 104. Latin America Mental Disorders Drugs Sales by Country (2024-2029) & (US$ Million)

Table 105. Latin America Mental Disorders Drugs Sales Market Share in Value by Country (2024-2029)

Table 106. Middle East and Africa Mental Disorders Drugs Sales by Country (2018-2023) & (K Units)

Table 107. Middle East and Africa Mental Disorders Drugs Sales Market Share in Volume by Country (2018-2023)

Table 108. Middle East and Africa Mental Disorders Drugs Sales by Country (2018-2023) & (US$ Million)

Table 109. Middle East and Africa Mental Disorders Drugs Sales Market Share in Value by Country (2018-2023)

Table 110. Middle East and Africa Mental Disorders Drugs Sales by Country (2024-2029) & (K Units)

Table 111. Middle East and Africa Mental Disorders Drugs Sales Market Share in Volume by Country (2024-2029)

Table 112. Middle East and Africa Mental Disorders Drugs Sales by Country (2024-2029) & (US$ Million)

Table 113. Middle East and Africa Mental Disorders Drugs Sales Market Share in Value by Country (2024-2029)

Table 114. Johnson & Johnson Company Information

Table 115. Johnson & Johnson Introduction and Business Overview

Table 116. Johnson & Johnson Mental Disorders Drugs Sales (K Units), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)

Table 117. Johnson & Johnson Mental Disorders Drugs Product

Table 118. Johnson & Johnson Recent Development

Table 119. Pfizer Company Information

Table 120. Pfizer Introduction and Business Overview

Table 121. Pfizer Mental Disorders Drugs Sales (K Units), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)

Table 122. Pfizer Mental Disorders Drugs Product

Table 123. Pfizer Recent Development

Table 124. Eli Lilly Company Information

Table 125. Eli Lilly Introduction and Business Overview

Table 126. Eli Lilly Mental Disorders Drugs Sales (K Units), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)

Table 127. Eli Lilly Mental Disorders Drugs Product

Table 128. Eli Lilly Recent Development

Table 129. GlaxoSmithKline Company Information

Table 130. GlaxoSmithKline Introduction and Business Overview

Table 131. GlaxoSmithKline Mental Disorders Drugs Sales (K Units), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)

Table 132. GlaxoSmithKline Mental Disorders Drugs Product

Table 133. GlaxoSmithKline Recent Development

Table 134. AstraZeneca Company Information

Table 135. AstraZeneca Introduction and Business Overview

Table 136. AstraZeneca Mental Disorders Drugs Sales (K Units), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)

Table 137. AstraZeneca Mental Disorders Drugs Product

Table 138. AstraZeneca Recent Development

Table 139. Bristol-Myers Squibb Company Information

Table 140. Bristol-Myers Squibb Introduction and Business Overview

Table 141. Bristol-Myers Squibb Mental Disorders Drugs Sales (K Units), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)

Table 142. Bristol-Myers Squibb Mental Disorders Drugs Product

Table 143. Bristol-Myers Squibb Recent Development

Table 144. Abbott Laboratories Company Information

Table 145. Abbott Laboratories Introduction and Business Overview

Table 146. Abbott Laboratories Mental Disorders Drugs Sales (K Units), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)

Table 147. Abbott Laboratories Mental Disorders Drugs Product

Table 148. Abbott Laboratories Recent Development

Table 149. Key Raw Materials Lists

Table 150. Raw Materials Key Suppliers Lists

Table 151. Mental Disorders Drugs Market Trends

Table 152. Mental Disorders Drugs Market Drivers

Table 153. Mental Disorders Drugs Market Challenges

Table 154. Mental Disorders Drugs Market Restraints

Table 155. Mental Disorders Drugs Distributors List

Table 156. Mental Disorders Drugs Downstream Customers

Table 157. Research Programs/Design for This Report

Table 158. Key Data Information from Secondary Sources

Table 159. Key Data Information from Primary Sources

List of Figures

Figure 1. Mental Disorders Drugs Product Picture

Figure 2. Global Mental Disorders Drugs Market Size, 2018 VS 2022 VS 2029 (US$ Million)

Figure 3. Global Mental Disorders Drugs Market Size Status and Outlook (2018-2029) & (US$ Million)

Figure 4. Global Mental Disorders Drugs Sales Status and Outlook (2018-2029) & (K Units)

Figure 5. Product Picture of Drugs for Schizophrenia

Figure 6. Global Drugs for Schizophrenia Sales YoY Growth (2018-2029) & (K Units)

Figure 7. Product Picture of Antidepressants

Figure 8. Global Antidepressants Sales YoY Growth (2018-2029) & (K Units)

Figure 9. Product Picture of Antipsychotics

Figure 10. Global Antipsychotics Sales YoY Growth (2018-2029) & (K Units)

Figure 11. Product Picture of Anxiolytics

Figure 12. Global Anxiolytics Sales YoY Growth (2018-2029) & (K Units)

Figure 13. Product Picture of Drugs for the Treatment of Substance and Alcohol Addiction

Figure 14. Global Drugs for the Treatment of Substance and Alcohol Addiction Sales YoY Growth (2018-2029) & (K Units)

Figure 15. Product Picture of Drugs for Childhood and Adolescent Mental Illness

Figure 16. Global Drugs for Childhood and Adolescent Mental Illness Sales YoY Growth (2018-2029) & (K Units)

Figure 17. Product Picture of Drugs to Treat Cognitive Disorders

Figure 18. Global Drugs to Treat Cognitive Disorders Sales YoY Growth (2018-2029) & (K Units)

Figure 19. Product Picture of Sleep Disorders

Figure 20. Global Sleep Disorders Sales YoY Growth (2018-2029) & (K Units)

Figure 21. Product Picture of Others

Figure 22. Global Others Sales YoY Growth (2018-2029) & (K Units)

Figure 23. Global Mental Disorders Drugs Sales by Type (2018-2029) & (US$ Million)

Figure 24. Global Mental Disorders Drugs Sales Market Share by Type in 2022 & 2029

Figure 25. North America Mental Disorders Drugs Sales Market Share in Volume by Type in 2022

Figure 26. North America Mental Disorders Drugs Sales Market Share in Value by Type in 2022

Figure 27. Europe Mental Disorders Drugs Sales Market Share in Volume by Type in 2022

Figure 28. Europe Mental Disorders Drugs Sales Market Share in Value by Type in 2022

Figure 29. Asia-Pacific Mental Disorders Drugs Sales Market Share in Volume by Type in 2022

Figure 30. Asia-Pacific Mental Disorders Drugs Sales Market Share in Value by Type in 2022

Figure 31. Latin America Mental Disorders Drugs Sales Market Share in Volume by Type in 2022

Figure 32. Latin America Mental Disorders Drugs Sales Market Share in Value by Type in 2022

Figure 33. Middle East and Africa Mental Disorders Drugs Sales Market Share in Volume by Type in 2022

Figure 34. Middle East and Africa Mental Disorders Drugs Sales Market Share in Value by Type in 2022

Figure 35. The 5 and 10 Largest Manufacturers in the World: Market Share by Mental Disorders Drugs Sales in 2022

Figure 36. The 5 and 10 Largest Manufacturers in the World: Market Share by Mental Disorders Drugs Revenue in 2022

Figure 37. Mental Disorders Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022

Figure 38. Product Picture of Children

Figure 39. Global Children Sales YoY Growth (2018-2029) & (K Units)

Figure 40. Product Picture of Adolescents

Figure 41. Global Adolescents Sales YoY Growth (2018-2029) & (K Units)

Figure 42. Product Picture of Adults

Figure 43. Global Adults Sales YoY Growth (2018-2029) & (K Units)

Figure 44. Global Mental Disorders Drugs Sales by Application (2018-2029) & (US$ Million)

Figure 45. Global Mental Disorders Drugs Sales Market Share by Application in 2022 & 2029

Figure 46. North America Mental Disorders Drugs Sales Market Share in Volume by Application in 2022

Figure 47. North America Mental Disorders Drugs Sales Market Share in Value by Application in 2022

Figure 48. Europe Mental Disorders Drugs Sales Market Share in Volume by Application in 2022

Figure 49. Europe Mental Disorders Drugs Sales Market Share in Value by Application in 2022

Figure 50. Asia-Pacific Mental Disorders Drugs Sales Market Share in Volume by Application in 2022

Figure 51. Asia-Pacific Mental Disorders Drugs Sales Market Share in Value by Application in 2022

Figure 52. Latin America Mental Disorders Drugs Sales Market Share in Volume by Application in 2022

Figure 53. Latin America Mental Disorders Drugs Sales Market Share in Value by Application in 2022

Figure 54. Middle East and Africa Mental Disorders Drugs Sales Market Share in Value by Application in 2022

Figure 55. Key Raw Materials Price

Figure 56. Mental Disorders Drugs Manufacturing Cost Structure

Figure 57. Mental Disorders Drugs Industrial Chain Analysis

Figure 58. Channels of Distribution

Figure 59. Distributors Profiles

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Electroconvulsive Therapy Devices Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-25U13933

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Treatment Resistant Depression Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-23D13294

Tue Mar 26 00:00:00 UTC 2024

Add to Cart

Amnestic Disorders Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-10L13491

Tue Mar 26 00:00:00 UTC 2024

Add to Cart

Quetiapine Fumarate - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-21U8990

Fri Mar 22 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions